Biotech Late Stage Investors & VC Firms
90 firms in this list, with a median first check of $4.1M. 25 of them lead rounds. Generated from verified public data and updated continuously.
Andreessen Horowitz
Menlo ParkSeed–Late Stage
F-Prime Capital Partners
BostonPre-Seed–Late Stage
Khosla Ventures
Menlo ParkSeed–Late Stage
Bessemer Venture Partners
LarchmontSeed–Late Stage
B4 Capital
Manhattan BeachPre-Seed–Late Stage
DCVC (Data Collective)
San FranciscoPre-Seed–Late Stage
Basecamp Fund
ManchesterPre-Seed–Late Stage$100K – $10M
Cambridge Innovation Capital
Cambridge, CambsSeed–Late Stage
GV (Google Ventures)
Mountain ViewSeed–Late Stage
5AM Ventures
BostonSeed–Late Stage
SV Health Investors
BostonPre-Seed–Late Stage
Deerfield Management Company
New YorkGrowth–Late Stage
OrbiMed
New YorkPre-Seed–Late Stage
Foresite Capital
West HollywoodPre-Seed–Late Stage
Giant Ventures Global Llp
LondonPre-Seed–Late Stage
Advent Life Sciences
LondonSeed–Late Stage
LSP (Life Sciences Partners)
StockholmSeries A–Late Stage$10M – $60M
Nextech Invest
ZurichSeed–Late Stage
Sanofi Ventures
Seed–Late Stage
Sofinnova Partners
ParisPre-Seed–Late Stage
Vida Ventures
Los AngelesPre-Seed–Late Stage
Syncona
LondonPre-Seed–Late Stage
GroveStreet
NewtonSeries A–Late Stage
Summit Partners
BostonSeries B–Late Stage$10M – $500M
Related lists
Late Stage Investors & VC Firms (1479)Biotech Investors & VC Firms (320)Biotech Seed Investors & VC Firms (255)Biotech Series A Investors & VC Firms (228)Biotech Pre-Seed Investors & VC Firms (153)Biotech Series B Investors & VC Firms (148)AI & Machine Learning Late Stage Investors & VC Firms (146)Healthtech Late Stage Investors & VC Firms (118)Biotech Growth Investors & VC Firms (104)Fintech Late Stage Investors & VC Firms (98)
Data sourced from public filings and firms' own websites — see our methodology.